Challenges – Labs war
Christophe Pouchoy, Managing Director and Chief Investment Officer of Trecento Asset Management, co-manager of the Trecento Santé fund, answered Challenges magazine’s questions about big pharmas’ appetite for the oncology market and its growth prospects, as evidenced by recent acquisitions (Celgene, Loxo Oncology …) for several billions of dollars. Christophe Pouchoy traced the evolutions of the…